Alexion Pharmaceuticals
Yan Wang is an experienced professional in health economics and outcomes research, currently serving as Director of Global Health Economics and Outcomes Research at Alexion Pharmaceuticals, Inc. since August 2019, after progressing from the role of Associate Director. Prior to this, Yan spent over five years as a Senior Health Economist at ghg | greyhealth group, focusing on HEOR and market access strategy as part of the WPP Health Practice. Yan holds a PhD in Applied Mathematics from the University of Pennsylvania and has a Master's and Bachelor's degree in Mathematics and Applied Mathematics, respectively, from Nanjing University.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
45 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.